Member Info for zahirmiahoutlook

Some twitchy fingers I guess

489k buy Vs 139k sell chill MM tree shake time

I think everyone here is lucky to get under 200p last week it hit above 280p so just hold tight

459K buy vs 129k sold not long now

Anyway enjoy the rise will be hitting a new high this week ;)

getting the placement is like winning the lottery, might aswell play the lotto then hope to get some On the placement

4 times more buys then sell only heading north now

In to the blue, ignore the muppets and DYOR before losing your money this will rise very quickly so don’t miss the boat :)

At the moment we’re on 3 X more buys then sell looking good

Remember RNS due anytime low Mcap 60M Avct Mcap 250M so expect this yo hit 600p to reach Avct Mcap

They need our shares can dummy sell all my shares but holding on to it for the long run :)

220p finish expected

DYOR RNS due anytime

Genedive kit would be manufactured by partner Cyvitia, formerly GE Healthcare Life Sciences.

Genedrive has contract with the US Department of Defense for testing for pathogens either in the air or in blood samples has been renewed; it also provides testing in Africa where the distance from a lab is frequently an issue and has developed a test for a genetic mutation in newborns who may lose their hearing if given antibiotics.

While this is not much different from other test providers working with the NHS it does add to the numbers currently needed to carry out a sufficiently largeamount of testing across the country.

Genedrive plans to adopt the process so that its portable machines can be used to allow immediate testing on site. Looking at the broader picture, although the UK is only days away from starting to loosen its lockdown, the latest figures of over 6,000 of new COVID cases per day and more than 600 deaths per day show that it is far too early to start relaxing.

For the rest of the year COVID will play a role in how industries and businesses go back to work and end up working more longer term, with scars particularly deeply felt by the travel, hospitality and entertainment sectors.

For Genedrive this means that its technology could be offered not only to the NHS but potentially also to businesses and industries, or alternatively, outside of the UK. This time the rally in Genedrive’s shares is likely to be supported by a much more solid offering in terms of products and ensure that it has legs.

Genedive kit would be manufactured by partner Cyvitia, formerly GE Healthcare Life Sciences.

Genedrive has contract with the US Department of Defense for testing for pathogens either in the air or in blood samples has been renewed; it also provides testing in Africa where the distance from a lab is frequently an issue and has developed a test for a genetic mutation in newborns who may lose their hearing if given antibiotics.

While this is not much different from other test providers working with the NHS it does add to the numbers currently needed to carry out a sufficiently largeamount of testing across the country.

Genedrive plans to adopt the process so that its portable machines can be used to allow immediate testing on site. Looking at the broader picture, although the UK is only days away from starting to loosen its lockdown, the latest figures of over 6,000 of new COVID cases per day and more than 600 deaths per day show that it is far too early to start relaxing.

For the rest of the year COVID will play a role in how industries and businesses go back to work and end up working more longer term, with scars particularly deeply felt by the travel, hospitality and entertainment sectors.

For Genedrive this means that its technology could be offered not only to the NHS but potentially also to businesses and industries, or alternatively, outside of the UK. This time the rally in Genedrive’s shares is likely to be supported by a much more solid offering in terms of products and ensure that it has legs.

GLA and DYOR will hold can see this going towards 600p soon

30 min left

Big orders into the close

Into the blue

No one wants to lose out on not being in, most likely this will shoot up 2M buy V 800k sell